These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25784136)

  • 1. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Saitoh D; Gando S; Thachil J
    Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
    Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
    Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
    Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
    Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC).
    Iba T; Maier CL; Tanigawa T; Levy JH
    Sci Rep; 2023 Dec; 13(1):22502. PubMed ID: 38110515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
    Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
    Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
    Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
    Kuroda H; Masuda Y
    Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of antithrombin III supplementation in an overt disseminated intravascular coagulation: a longitudinal single-institutional experience and retrospective analysis.
    Lee S; Kim J; Ji M; Moon H; Lee W
    Ann Palliat Med; 2024 May; 13(3):477-495. PubMed ID: 38735696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
    Tagami T
    J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
    Wiedermann CJ; Kaneider NC
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.
    Iba T; Arakawa M; Mochizuki K; Nishida O; Wada H; Levy JH
    Clin Appl Thromb Hemost; 2019; 25():1076029618824044. PubMed ID: 30808223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
    Kuroda H; Tatsumi H; Sonoda T; Masuda Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
    Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
    Choi Q; Hong KH; Kim JE; Kim HK
    Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
    Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
    Iba T; Saitoh D; Wada H; Asakura H
    Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.